Refrigerated Storage


0.9 mg powder for solution for injection

Contact Genzyme Therapeutics in all cases where a deviation from the recommended storage conditions has occurred.

Refer to the current BNF for company contact details

Genzyme advise that individuals contact them each time for requests regarding extended stability of their products to ensure that the most current information is reflected and any individual specific stability questions can be addressed.

17 December 2019
London Medicines Information Service

Lactation Safety Information

TSH, thyroid stimulating hormone

TSH, thyroid stimulating hormone
Minimal absorption from the infant's GI tract
Normal component of breast-milk although no published evidence of safety when used therapeutically
Use in breastfeeding will be limited as normally used in conjunction with radio-iodine (which is contraindicated with breastfeeding)
17 September 2020